Education
About Us
Working with TipRanks
Follow Us
Brooks Laboratories Limited (IN:BROOKS)
:BROOKS
RESEARCH TOOLSreports
BROOKS Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹97.80 - ₹202.80
Previous CloseN/A
Volume3.81K
Average Volume (3M)3.15K
Market Cap
₹4.09B
Enterprise Value₹3.98B
Total Cash (Recent Filing)₹8.08M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)348.2
Beta1.32
Next Earnings
Nov 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.25
Shares Outstanding29,457,249
10 Day Avg. Volume1,617
30 Day Avg. Volume3,151
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹135.00Price Target Upside-0.95% Downside
Rating ConsensusHold
Number of Analyst Covering0
BROOKS FAQ
What was Brooks Laboratories Limited’s price range in the past 12 months?
Brooks Laboratories Limited lowest stock price was ₹97.80 and its highest was ₹202.80 in the past 12 months.
What is Brooks Laboratories Limited’s market cap?
Brooks Laboratories Limited’s market cap is ₹4.09B.
When is Brooks Laboratories Limited’s upcoming earnings report date?
Brooks Laboratories Limited’s upcoming earnings report date is Nov 07, 2025 which is in 64 days.
How were Brooks Laboratories Limited’s earnings last quarter?
Brooks Laboratories Limited released its earnings results on Aug 13, 2025. The company reported ₹3.254 earnings per share for the quarter, beating the consensus estimate of N/A by ₹3.254.
Is Brooks Laboratories Limited overvalued?
According to Wall Street analysts Brooks Laboratories Limited’s price is currently Overvalued.
Does Brooks Laboratories Limited pay dividends?
Brooks Laboratories Limited does not currently pay dividends.
What is Brooks Laboratories Limited’s EPS estimate?
Brooks Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brooks Laboratories Limited have?
Brooks Laboratories Limited has 29,457,249 shares outstanding.
What happened to Brooks Laboratories Limited’s price movement after its last earnings report?
Brooks Laboratories Limited reported an EPS of ₹3.254 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.858%.
Which hedge fund is a major shareholder of Brooks Laboratories Limited?
Currently, no hedge funds are holding shares in IN:BROOKS
Company Description
Brooks Laboratories Limited
Brooks Laboratories Limited (BROOKS) is a pharmaceutical company based in India, primarily engaged in the manufacturing and marketing of a broad range of pharmaceutical products. The company specializes in the production of various formulations in the antibiotic, anti-diabetic, cardiovascular, and gastroenterology segments. Brooks Laboratories has established a presence in both domestic and international markets, focusing on delivering quality healthcare solutions.
Technical Analysis
Albert David Ltd
―
Medicamen Biotech Limited
―
Medico Remedies Ltd.
―
Nectar Lifesciences Ltd.
―
Zim Laboratories Ltd.
―